These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22382478)

  • 1. The role of mucoregulatory agents after continence-preserving urinary diversion surgery.
    Covert WM; Westin SN; Soliman PT; Langley GD
    Am J Health Syst Pharm; 2012 Mar; 69(6):483-6. PubMed ID: 22382478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing mucus production after urinary reconstruction: a prospective randomized trial.
    N'Dow J; Robson CN; Matthews JN; Neal DE; Pearson JP
    J Urol; 2001 May; 165(5):1433-40. PubMed ID: 11342892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dissolution of urinary mucus after cystoplasty.
    Gillon G; Mundy AR
    Br J Urol; 1989 Apr; 63(4):372-4. PubMed ID: 2713619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Long-Acting Octreotide on Reducing Mucus Production in Patients With Ileal Neobladder.
    Khorrami MH; Javid A; Izadpanahi MH; Alizadeh F; Zargham M; Khorrami F
    Clin Genitourin Cancer; 2017 Feb; 15(1):e9-e13. PubMed ID: 27894777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic effect of a somatostatin analogue in decreasing mucus production by the intestinal segment after enterocystoplasty.
    Khorrami MH; Salehi P; Nouri-Mahdavi K; Ghalamkari A; Tadayyon F
    J Urol; 2008 Dec; 180(6):2501-3. PubMed ID: 18930479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of N-acetyl-L-cysteine on the viscosity of ileal neobladder mucus.
    Schrier BP; Lichtendonk WJ; Witjes JA
    World J Urol; 2002 May; 20(1):64-7. PubMed ID: 12088194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine versus ranitidine plus octreotide in the treatment of acute non-variceal upper gastrointestinal bleeding: a prospective randomised study.
    Archimandritis A; Tsirantonaki M; Tryphonos M; Kourtesas D; Sougioultzis S; Papageorgiou A; Tzivras M
    Curr Med Res Opin; 2000; 16(3):178-83. PubMed ID: 11191007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model systems for the evaluation of mucolytic drugs: acetylcysteine and S-carboxymethylcysteine.
    Livingstone CR; Andrews MA; Jenkins SM; Marriott C
    J Pharm Pharmacol; 1990 Feb; 42(2):73-8. PubMed ID: 1972405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nesosteine: a new mucoregulatory agent.
    Scuri R; Mondani P; Frova C; Fantini L
    Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
    De Lisle RC; Roach E; Jansson K
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of urea for dissolution of urinary mucus in urinary tract reconstruction.
    Bushman W; Howards SS
    J Urol; 1994 Apr; 151(4):1036-7. PubMed ID: 8126784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mucolytic and mucoregulatory agents].
    Yernault JC
    Rev Med Brux; 1987 Oct; 8(8):423. PubMed ID: 3423520
    [No Abstract]   [Full Text] [Related]  

  • 13. Octreotide for arrest of peptic ulcer hemorrhage--a prospective, randomized controlled trial.
    Lin HJ; Perng CL; Wang K; Lee CH; Lee SD
    Hepatogastroenterology; 1995; 42(6):856-60. PubMed ID: 8847035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine: forgotten drug of delayed gastric emptying.
    Veevers AE; Oxberry SG
    BMJ Support Palliat Care; 2017 Sep; 7(3):255-257. PubMed ID: 28159802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucus production after transposition of intestinal segments into the urinary tract.
    N'Dow J; Pearson J; Neal D
    World J Urol; 2004 Sep; 22(3):178-85. PubMed ID: 15290207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral N-acetylcysteine on mucus clearance.
    Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
    Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental study of the rat for the assessment of barium coating on the gastric mucosa: efficacy of ranitidine and acetylcysteine administration.
    Sugino Y; Semmler W
    Radiat Med; 2004; 22(3):173-8. PubMed ID: 15287533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The appropriate use of mucolytic agents.
    Lieberman J
    Am J Med; 1970 Jul; 49(1):1-4. PubMed ID: 4246985
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to the Editor on: Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion.
    Adeli SH; Jazi K
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):2986-2987. PubMed ID: 38708454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.